85817229 - SYNTHETX

Information

  • Trademark
  • 85817229
  • Serial Number
    85817229
  • Filing Date
    January 07, 2013
    11 years ago
  • Transaction Date
    January 08, 2015
    9 years ago
  • Status Date
    January 08, 2015
    9 years ago
  • Location Date
    January 08, 2015
    9 years ago
  • Status Code
    602
  • Current Location
    TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    KUYKENDALL, LINDSEY
  • Attorney Docket Number
    60895-342797
    Attorney Name
    Mark Harrison
    Law Office Assigned Location Code
    L20
  • Owners
Mark Drawing Code
4000
Mark Identification
SYNTHETX
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Human cells and isogenic cell lines for scientific, laboratory or medical research; genomic reference control samples for medical laboratory use; Molecular biology research tools, in the nature of biological and biochemical reagents, specifically, genomic DNA; DNA repair enzymes for scientific and research purposes; Biological and chemical reagents, namely, genomic DNA, cell cultures and mutant and normal isogenic human cell line pairs, for research use
  • GS0051: Protein cell lysates, genornic DNA preparations and formalin fixed, paraffin embedded (FFPE) engineered tumor tissue mimics for medical diagnostic use
  • GS0421: Custom cell-line engineering services; Scientific research in the field of genetics and genetic engineering, namely, gene-editing services, DNA modeling services, gene engineering services, establishing patient genotypes; Bio-technology, pharmaceutical and scientific testing, research and development services relating to genetics, and providing advice, consultancy and information services related thereto; biological research; pharmaceutical research services; drug discovery services; Scientific research and development services for lead identification and validation; Scientific research and development services for target identification and validation; Pharmaceutical research, namely, identification of patient-relevant drug targets, optimization of drug candidates for clinical development; Laboratory diagnostic services, namely, diagnosis of genetic mutations for clinical or research purposes and the design of molecular reference standards for assay development, clinical diagnostic quality control and proficiency schemes for the medical diagnostic services industry; medicinal research services, namely, hit discovery and hit to lead services; research and development services in the nature of creating libraries and collections of cells and cell lines, chemicals and compounds; research and development services in the nature of creating libraries and collections of normal and mutated genes; Scientific research and development services relating to targeting therapies to individuals; Scientific research and development services relating to combining therapies for individuals; research and development relating to reagents; Scientific research in the field of disease modeling; Medical and scientific research, namely, designing and conducting clinical trials for others; research and development in re-positioning existing drugs from other therapeutic indications
  • PM0000: SYNTHETIC
Case File Event Statements
  • 1/8/2015 - 9 years ago
    29 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 1/8/2015 - 9 years ago
    28 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 6/12/2014 - 10 years ago
    27 - NON-FINAL ACTION MAILED Type: CNRT
  • 6/11/2014 - 10 years ago
    26 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/11/2014 - 10 years ago
    25 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 5/18/2014 - 10 years ago
    24 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 5/2/2014 - 10 years ago
    23 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 5/1/2014 - 10 years ago
    22 - EXAMINERS AMENDMENT MAILED Type: CNEA
  • 4/30/2014 - 10 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/30/2014 - 10 years ago
    20 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/30/2014 - 10 years ago
    19 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/25/2014 - 10 years ago
    18 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 4/25/2014 - 10 years ago
    17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/15/2014 - 10 years ago
    16 - PAPER RECEIVED Type: MAIL
  • 11/4/2013 - 11 years ago
    15 - NON-FINAL ACTION MAILED Type: CNRT
  • 11/1/2013 - 11 years ago
    14 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/17/2013 - 11 years ago
    13 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 10/17/2013 - 11 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/10/2013 - 11 years ago
    11 - PAPER RECEIVED Type: MAIL
  • 4/11/2013 - 11 years ago
    10 - NON-FINAL ACTION MAILED Type: CNRT
  • 4/10/2013 - 11 years ago
    9 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/8/2013 - 11 years ago
    8 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/21/2013 - 11 years ago
    7 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 2/21/2013 - 11 years ago
    6 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/13/2013 - 11 years ago
    5 - ASSIGNED TO LIE Type: ALIE
  • 2/8/2013 - 11 years ago
    4 - PAPER RECEIVED Type: MAIL
  • 1/17/2013 - 11 years ago
    3 - NOTICE OF PSEUDO MARK MAILED Type: MPMK
  • 1/16/2013 - 11 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 1/10/2013 - 11 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP